SIRT1 and colitis: (27) found that the SIRT1 activator SRT1720 decreases the disease activity index, inflammatory cytokine levels, and colon histological score in mice with DSS-induced colitis, whereas nicotinamide (SIRT1 inhibitor) administration exerts the opposite effects.